PPRC1 and benign prostatic hyperplasia: Fig. 2 shows that treatment of PC3 cells and primary cultures of PrC and BPH for 48 h with the different endocannabinoids (at 2.5, 5.0 and 10 μM concentrations) significantly decreased the viability of the cells (P<0.05).